HealthEisai and Biogen Report Five-Year Leqembi Results Against External CohortsBy Naomi CalderNov 17, 2026, 8:43 AM UTC
TechnologyAmodei Says AI Could Make Four Diseases Less Intractable in Less Than 10 YearsBy Elias MercerNov 12, 2026, 3:21 AM UTC
HealthAcumen Stock Drops Sharply After Alzheimer’s Study SetbackBy Naomi CalderOct 30, 2026, 2:42 PM UTC
HealthEisai Plans Five-Year Lecanemab Findings and Clinic Studies at CTADBy Naomi CalderOct 30, 2026, 7:31 AM UTC
HealthEli Lilly Licenses ADDF Speech Dataset for Alzheimer’s ResearchBy Naomi CalderOct 28, 2026, 8:35 PM UTC
HealthFDA Starts Neuroscience Program With Alzheimer’s Prevention as First FocusBy Naomi CalderOct 23, 2026, 5:00 AM UTC